Yousif Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,721
Closed -$226K 1859
2025
Q4
$226K Sell
8,721
-552
-6% -$14.2K ﹤0.01% 1742
2025
Q3
$247K Sell
9,273
-1,805
-16% -$46.6K ﹤0.01% 1720
2025
Q2
$254K Sell
11,078
-37
-0.3% -$918 ﹤0.01% 1736
2025
Q1
$322K Sell
11,115
-231
-2% -$7.38K ﹤0.01% 1620
2024
Q4
$421K Sell
11,346
-410
-3% -$18.7K ﹤0.01% 1547
2024
Q3
$571K Sell
11,756
-426
-3% -$18.7K 0.01% 1441
2024
Q2
$487K Sell
12,182
-1,525
-11% -$63.2K 0.01% 1482
2024
Q1
$602K Sell
13,707
-2,961
-18% -$153K 0.01% 1440
2023
Q4
$1.03M Sell
16,668
-1,060
-6% -$55.7K 0.01% 1207
2023
Q3
$815K Sell
17,728
-1,104
-6% -$60.2K 0.01% 1241
2023
Q2
$1.08M Sell
18,832
-1,595
-8% -$70.7K 0.01% 1105
2023
Q1
$766K Sell
20,427
-3,220
-14% -$106K 0.01% 1285
2022
Q4
$663K Sell
23,647
-4,645
-16% -$135K 0.01% 1374
2022
Q3
$795K Buy
28,292
+163
+0.6% +$5.32K 0.01% 1308
2022
Q2
$979K Sell
28,129
-3,040
-10% -$108K 0.01% 1246
2022
Q1
$1.12M Sell
31,169
-4,460
-13% -$126K 0.01% 1300
2021
Q4
$830K Buy
+35,629
New +$729K 0.01% 1451

Other funds holding AMPH

Yousif Capital Management's AMPH Position: Q1 2026 in Review

Yousif Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 8,721 shares — an estimated $226K sold.

Yousif Capital Management first reported a position in AMPH in Q4 2021 and held it in 17 quarters. The position peaked at $1.12M in Q1 2022. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Yousif Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Yousif Capital Management sold 8,721 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $226K.
  • Yousif Capital Management first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 17 quarters.
  • Yousif Capital Management's Amphastar Pharmaceuticals position peaked at $1.12M in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Yousif Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.